Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

about

Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection.Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB.

P2860

Q52665654-B77D3E85-B991-450D-8A58-3D35063DC5B6 Q55385233-587AEC3D-C221-4E8D-B35E-8E4C3C6BCE6C

P2860

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

Item

http://www.wikidata.org/entity/Q39410146

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

@en

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer.

@nl

type

Item

label

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

@en

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer.

@nl

prefLabel

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

@en

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer.

@nl

P1476

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

@en

P2093

Jurgen J Fütterer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

ESUR prostate MR guidelines 2012

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges.

Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.

Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

P304

597-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3348/KJR.2017.18.4.597

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28670154

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

P932

5447635

http://www.w3.org/2001/XMLSchema#string

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

about

P2860

P2860

Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932